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Abstract
Raoultella ornithinolytica is belongs to the family of Enterobacteriaceae, a Gram-negative encapsulated aerobic
bacillus associated with bacteremia and urinary tract infections. As biofield therapy is increasingly popular in
biomedical heath care, so present study aimed to evaluate the impact of Mr. Trivedi’s biofield treatment on
antimicrobial sensitivity, minimum inhibitory concentration (MIC), biochemical study, and biotype number of
multidrug resistant strain of R. ornithinolytica. Clinical sample of R. ornithinolytica was divided into two groups i.e.
control and biofield treated which were analyzed for the above parameters using MicroScan Walk-Away® system on
day 10 after treatment. Antimicrobial sensitivity assay results showed a significant increase (60.71%) in sensitivity
pattern of antimicrobials i.e. changed from resistant to susceptible while 10.71% of tested antimicrobials changed
from intermediate to susceptible as compared to control. MIC results showed a significant decrease in MIC values of
71.88% tested antimicrobials as compared to control.
Biochemical reaction study showed 15.15% alteration in different biochemical such as cetrimide, cephalothin,
kanamycin, and ornithine after biofield treatment as compared to control. A significant change in biotype number
(7775 4370) was also observed with organism identified as Klebsiella oxytoca after biofield treatment as compared
to control (7775 5372). Overall results conclude that biofield treatment could be used as complementary and
alternative treatment strategy against multidrug resistant strain of R. ornithinolytica with respect to improve the
sensitivity and reduce the MIC values of antimicrobials. Hence, it is assumed that biofield treatment might be a
suitable cost effective treatment strategy in near future, which could have therapeutic value in patients suffering from
multidrug resistant pathogens.
Keywords: Raoultella ornithinolytica; Biofield treatment;
Antimicrobial susceptibility; Biochemical reaction; Biotype; Multidrug
resistant
Introduction
Genus Raoultella belongs to the family Enterobacteriaceae, mainly
contains Gram-negative, aerobic, non-motile, capsulated, and
facultative anaerobic bacilli [1]. Initially, genus Raoultella was
classified in Klebsiella, further on the basis of 16S rRNA and rpoB
genes study includes it in new genus Raoultella. It includes Raoultella
ornithinolytica, R. electrica, R. planticola, and R. terrigena. R.
ornithinolytica is widely distributed in aquatic flora, fishes and insects,
but it was associated with histamine poisoning in fish [2]. Human
infections are often less reported earlier, but different cases of
bacteremia are reported due to R. terrigena [3], R. planticola [4] and R.
ornithinolytica [5,6].
Although most of the infectious cases are often associated with
underlying existing infection especially malignancies. However, other
pathogenic cases such as urinary tract infection, soft issue infections in
adults and neonatal infections are also reported [7]. Thus, this is very
clear from the above reports that Raoultella genus acts as human
pathogen and multidrug resistant (MDR) strain will cause a serious
threat to human health causing pneumonia and other infections [8].
Broad spectrum antimicrobials and combinations therapies are the
only treatment strategy to cure the infection of MDR. Antimicrobials
are always associated with serious side effects [9]. Currently, no such
alternative therapies apart from medicines are available against MDR
microorganism infections, biofield treatment may be a new approach
to improve the susceptibility pattern of R. ornithinolytica.
The National Center for Complementary and Alternative Medicine
(NCCAM) places biofield therapy under subcategory of energy
therapies as one of the five complementary medicine domain. It is
scientifically preferred term for the biologically produced
electromagnetic and subtle energy field that provides regulatory and
communication functions within the organism. The cumulative effect
of bio-magnetic and electric field that surrounds the human body is
defined as biofield energy. However, the energy can exists in several
forms such as kinetic, potential, electrical, magnetic, and nuclear. But
human body has the power to produce measurable electric and
magnetic signals [10,11].
Similarly, the human nervous system consists of the energy and
chemical information in the form of electrical signals. Thus, human
has the ability to harness the energy from environment or universe
and can transmit into any living or nonliving object(s) around the
globe. The objects always receive the energy and responding into
useful way via biofield energy and the process is known as biofield
treatment. Even every cell of human body will produce minute
amount of magnetic and electric field, as it always covers with positive
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and negative charge in outer and inner cell wall respectively [12]. The
biofield energy can be monitored by using electromyography (EMG),
electrocardiography (ECG) and electroencephalogram (EEG) [13]. Mr.
Trivedi’s biofield treatment is well known and significantly studied in
different fields such as altering the sensitivity pattern of different
human pathogens [14-16]. It has been significantly studied in field of
agriculture [17-19], biotechnology [20,21], and in material science
[22-24].
Materials and Methods
Experimental design and biofield treatment
MDR strain of R. ornithinolytica was obtained from stored stock
cultures of clinical sample in Microbiology Lab, Hinduja Hospital,
Mumbai. MDR strain was divided in two groups i.e. control and
treatment. In case of treatment group, sealed pack of MDR strain of R.
ornithinolytica was handed over to Mr. Trivedi for biofield treatment
under laboratory conditions. Mr. Trivedi provided the treatment
through his energy transmission process to the treated group without
touching the sample. The biofield treated sample was returned in the
similar sealed condition and further analyzed on day 10 using the
standard protocols. After biofield treatment, following parameters like
antimicrobial susceptibility, MIC values, biochemical reactions, and
biotype number were measured using MicroScan Walk-Away® system
(Dade Behring Inc., USA) with respect to control. All antimicrobials
and biochemicals were procured from Sigma Aldrich.
Evaluation of antimicrobial susceptibility assay
Antimicrobial susceptibility pattern of R. ornithinolytica was
studied using MicroScan Walk-Away® system along with Negative
Break Point Combo (NBPC 30) panel as per manufacturer's
instructions. The antimicrobial susceptibility pattern (S: Susceptible, I:
Intermediate, and R: Resistant) and minimum inhibitory
concentration (MIC) values were determined by observing the lowest
antimicrobial concentration showing growth inhibition. The
antimicrobials used in the susceptibility assay viz. amikacin,
amoxicillin/k-clavulanate, ampicillin/sulbactam, ampicillin,
aztreonam, cafazolin, cefepime, cefotaxime, cefotetan, cefoxitin,
ceftazidime, ceftriaxone, cefuroxime, cephalothin, chloramphenicol,
ciprofloxacin, ESBL-a Scrn, ESBL-b Scrn, gatifloxacin, gentamicin,
imipenem, levofloxacin, meropenem, moxifloxacin, nitrofurantoin,
norfloxacin, piperacillin, piperacillin/tazobactam, tetracycline,
ticarcillin/k-clavulanate, and tobramycin, trimethoprim/
sulfamethoxazole [25].
Biochemical study
Biochemical study of R. ornithinolytica was determined using
MicroScan Walk-Away® system in both control and treated groups.
Biochemicals used in the study are acetamide, adonitol, arabinose,
arginine, cetrimide, cephalothin, citrate, colistin, esculin hydrolysis,
nitrofurantoin, glucose, hydrogen sulfide, indole, inositol, kanamycin,
lysine, malonate, melibiose, nitrate, oxidation-fermentation,
galactosidase, ornithine, oxidase, penicillin, raffinose, rhaminose,
sorbitol, sucrose, tartarate, tryptophan deaminase, tobramycin, urea,
and Voges-Proskauer [25].
Identification by biotype number
The biotype number of R. ornithinolytica in control and treated
samples were determined followed by identification of microorganism
by MicroScan Walk-Away® processed panel report with the help of
biochemical reaction data [25].
Results
Antimicrobial susceptibility
Results of antimicrobial sensitivity pattern and MIC values of
control and biofield treated MDR strain of R. ornithinolytica are
summarized in Tables 1 and 2, respectively. All these changes were
observed on day 10 after the biofield treatment as compared to control
group. Antimicrobial sensitivity assay showed that 60.71% of tested 28
antimicrobials were reported with significant increase in sensitivity
pattern from R → S viz. amoxicillin/k-clavulanate, ampicillin/
sulbactam, aztreonam, cefazolin, cefotaxime, ceftriaxone, cefuroxime,
cephalothin, ciprofloxacin, gatifloxacin, gentamicin, levofloxacin,
moxifloxacin, piperacillin, tetracycline, trimethoprim/
sulfamethoxazole, and tobramycin after biofield treatment. Apart from
this, 10.71% tested antimicrobials showed altered sensitivity pattern
from I → S in ceftazidime, piperacillin/tazobactam, and ticarcillin/k-
clavulanate as compared to control. Rest of the antimicrobials (28.7%)
did not show any alteration in sensitivity pattern (Table 1).
S. No. Antimicrobial Control Treated
1 Amikacin S S
2 Amoxicillin/k-clavulanate R S
3 Ampicillin/sulbactam R S
4 Ampicillin R R
5 Aztreonam R S
6 Cefazolin R S
7 Cefepime S S
8 Cefotaxime R S
9 Cefotetan S S
10 Cefoxitin S S
11 Ceftazidime I S
12 Ceftriaxone R S
13 Cefuroxime R S
14 Cephalothin R S
15 Chloramphenicol S S
16 Ciprofloxacin R S
17 Gatifloxacin R S
18 Gentamicin R S
19 Imipenem S S
20 Levofloxacin R S
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21 Meropenem S S
22 Moxifloxacin R S
23 Piperacillin R S
24 Piperacillin/tazobactam I S
25 Tetracycline R S
26. Ticarcillin/k-clavulanate I S
27. Tobramycin R S
28. Trimethoprim/sulfamethoxazole R S
R: Resistant; I: Intermediate; S: Susceptible
Table 1: Effect of biofield treatment on Raoultella ornithinolytica to
antimicrobial susceptibility.
Besides antimicrobial sensitivity assay, an overall significant
decrease in MIC values were reported in 71.88% of antimicrobials
(twenty three out of thirty two) against R. ornithinolytica as compared
to control. Four folds decreased in MIC value were observed in case of
cefotaxime, ceftriaxone, piperacillin, piperacillin/tazobactam,
ticarcillin/k-clavulanate, and cefuroxime while two folds decreased in
MIC value in case of amoxicillin/clavulanic acid, ampicillin/sulbactam,
aztreonam, cefazolin, cephalothin, ceftazidime, gentamicin,
norfloxacin, tetracycline, tobramycin, gatifloxacin, levofloxacin,
moxifloxacin, and ciprofloxacin. Trimethoprim/sulfamethoxazole was
reported with decreased MIC value (less than 2/38 µg/mL) as
compared to control (Figure 1 and Table 2).
Figure 1: Percentage change in antimicrobial sensitivity pattern,
minimum inhibitory concentration (MIC) values and biochemical
reactions after biofield treatment of multidrug resistant strain of
Raoultella ornithinolytica.
S. No. Antimicrobial Control(µg/mL)
Treated
(µg/mL)
1 Amikacin ≤16 ≤16
2 Amoxicillin/k-clavulanate >16/8 ≤8/4
3 Ampicillin/sulbactam >16/8 ≤8/4
4 Ampicillin >16 >16
5 Aztreonam >16 ≤8
6 Cefazolin >16 ≤8
7 Cefepime ≤8 ≤8
8 Cefotaxime >32 ≤8
9 Cefotetan ≤16 ≤16
10 Cefoxitin ≤8 ≤8
11 Ceftazidime 16 ≤8
12 Ceftriaxone >32 ≤8
13 Cefuroxime >16 ≤4
14 Cephalothin >16 ≤8
15 Chloramphenicol ≤8 ≤8
16 Ciprofloxacin >2 ≤1
17 ESBL-a Scrn >4 ≤4
18 ESBL-b Scrn >1 ≤1
19 Gatifloxacin >4 ≤2
20 Gentamicin >8 ≤4
21 Imipenem ≤4 ≤4
22 Levofloxacin >4 ≤2
23 Meropenem ≤4 ≤4
24 Moxifloxacin >4 ≤2
25 Nitrofurantoin ≤32 ≤32
26 Norfloxacin >8 ≤4
27 Piperacillin >64 ≤16
28 Piperacillin/tazobactam 64 ≤16
29 Tetracycline >8 ≤4
30 Ticarcillin/k-clavulanate 64 ≤16
31 Tobramycin >8 ≤4
32 Trimethoprim/sulfamethoxazole >2/38 ≤2/38
ESBL-a, b Scrn: Extended-Spectrum β-Lactamase screen.
Table 2: Minimum inhibitory concentration (MIC) of tested
antimicrobials on Raoultella ornithinolytica.
Biochemical reaction
Table 3 summarizes the data related to biochemical reactions in
control and biofield treated group. Results showed that, 15.15% tested
biochemical reactions out of 33 were changed from positive (+) to
negative (-) such as cetrimide, cephalothin, kanamycin, ornithine, and
tobramycin after biofield treatment as compared with control (Figure
1).
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S. No. Code Biochemical Control Treated
1 ACE Acetamide - -
2 ADO Adonitol + +
3 ARA Arabinose + +
4 ARG Arginine - -
5 CET Cetrimide + -
6 CF8 Cephalothin + -
7 CIT Citrate + +
8 CL4 Colistin - -
9 ESC Esculin hydrolysis + +
10 FD64 Nitrofurantoin - -
11 GLU Glucose + +
12 H2S Hydrogen sulfide - -
13 IND Indole + +
14 INO Inositol + +
15 K4 Kanamycin + -
16 LYS Lysine + +
17 MAL Malonate + +
18 MEL Melibiose + +
19 NIT Nitrate + +
20 OF/G Oxidation-Fermentation + +
21 ONPG Galactosidase + +
22 ORN Ornithine + -
23 OXI Oxidase - -
24 P4 Penicillin + +
25 RAF Raffinose + +
26 RHA Rhaminose + +
27 SOR Sorbitol + +
28 SUC Sucrose + +
29 TAR Tartrate - -
30 TDA Tryptophan Deaminase - -
31 TO4 Tobramycin + -
32 URE Urea + +
33 VP Voges-Proskauer + +
- (negative); + (positive)
Table 3: Effect of biofield treatment on Raoultella ornithinolytica to
the vital process of microorganism.
Organism identification by biotype number
Based on the biochemical results, change in biotype number was
observed in biofield treated group (7775 4370) at day 10 of R.
ornithinolytica with respect to control (7775 5372). After alteration in
biotype number the new organism was identified as Klebsiella oxytoca
(Table 4).
Feature Control Treated
Biotype 77755372 77754370
Organism
Identification
Raoultella ornithinolytica Klebsiella oxytoca
Table 4: Effect of biofield treatment on Raoultella ornithinolytica to
distinguishing feature of the genotype.
Discussion
MDR emergence of R. ornithinolytica is a global health problem
commonly associated with bacteremia, urinary tract infection,
neonatal infections, and exist in underlying existing infection
[6,26,27]. Increasing resistance in microorganism for antimicrobials
becomes a major threat to health and economic problem which
ultimately leads to allowing survival of the resistant bacteria and death
of the susceptible ones. Major mechanistic pathways associated with
resistant in microorganism are cell membrane alterations, which lead
to decreased uptake of drug [28]; mutation occurs, that lead to over
expression of drug target enzymes and the other common mechanism
being the drug efflux pump [29]. Now-a-days, R. ornithinolytica
acquired resistance against broad range of antimicrobials. Research
study suggests that most of the clinical isolates of R. ornithinolytica
were found resistant to all class of antimicrobials such as ampicillin,
amoxicillin, cephalothin, cephotaxime, chloramphenicol, penicillin,
gentamicin, rifampin, and streptomycin. Nitrofurantoin and
meropenam showed highest sensitivity for R. ornithinolytica in all the
clinical samples [30]. Our experimental control sample (R.
ornithinolytica) showed similar sensitivity and resistant pattern of
tested antimicrobials. Overall results showed increase in antimicrobial
sensitivity after biofield treatment in 71.4% tested antimicrobials as
compared to control. Mr. Trivedi’s biofield treatment has significantly
decreased the MIC values of 71.87% tested antimicrobials as compared
to control. As an enteric pathogen, R. ornithinolytica causes enteric
fever associated with syndrome like fever, headache, and abdominal
pain. Best treatment therapy during the infection starts with
amoxicillin/clavulanic acid for 10-14 days, but therapy depends upon
the sensitivity pattern of clinical strain [31]. Different class of
antimicrobials showed significant effect after biofield treatment viz. β-
Lactam penicillins (amoxicillin/clavulanic acid, ampicillin/sulbactam,
and piperacillin), cephalosporins (cefazolin, ceftriaxone, and
cefuroxime), monobactum (azetronan), fluoroquinolones
(ciprofloxacin and levofloxacin), aminoglycosides (amikacin and
tobramycin) and tetracycline. Lucchetti et al. studied the effect of
energy therapy as an alternate medicine on growth of bacterial culture,
and found a significant effect [32]. Similarly, experimental results
showed improved antimicrobial sensitivity and reduced MIC values
suggest that biofield treatment could be a new alternative treatment
approach to inhibit the growth of pathogenic bacteria.
Several phenotypic biochemical identification tests were available to
differentiate the Raoultella species. Identification test of R.
ornithinolytica was performed using a series of biochemical reactions
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and the basic positive reactions were observed in case of urea,
ornithine and lysine decarboxylase, citrate, glucose, and sucrose. It
generally grown at 10°C with utilization of L-sorbose as a carbon
source [33]. Experimental control group showed positive reaction in
above general characteristic of R. ornithinolytica, but biofield
treatment group showed a significant alteration i.e. negative reactions
in biochemical such as cetrimide, cephalothin, kanamycin, ornithine
and tobramycin. Further, these biochemical changes were studied by
biotype number analysis which was performed using an automated
system. A significant changed in biotype number was found in treated
group on day 10, and new organism was identified as Klebsiella
oxytoca after biofield treatment as compared to control R.
ornithinolytica (Table 4). Biofield treatment on pathogenic
microorganism had been reported, which alter the biochemical
reactions, followed by change biotype number and identification of
new microorganism after treatment. Current results are well
supported with recent reported study [34].
Overall results of antimicrobial assay suggest that Mr. Trivedi’s
biofield treatment has significantly improved the sensitivity and MIC
value of most of the tested antimicrobials (Figure 1). Therefore, it may
be possible that lower dose of antimicrobials might require with
similar response after biofield treatment, which may minimize the side
effects associated with higher doses of antimicrobials. Mr. Trivedi has
the ability to harness energy from environment and altered the
significant changes in microorganisms [15,16]. Biofield treatment
might be responsible to do alteration in microorganism at genetic level
and/or enzymatic level, which may act on receptor protein. While
altering receptor protein, ligand-receptor/protein interactions may
alter that could lead to show different phenotypic characteristics.
Biofield treatment might induce significant changes in MDR strain of
R. ornithinolytica, so that tested antimicrobials were showed better
susceptibility pattern, decreased MIC values, and altered biochemical
reactions, against this microorganism.
Conclusion
Present study concludes that biofield treatment has the ability to
inhibit the microbial growth, by significantly increasing the
susceptibility pattern and decreasing the MIC values of 71% tested
antimicrobials. Biofield treatment has significantly altered the
biochemical reactions and biotype number of MDR strain of R.
ornithinolytica. On the basis of changed biotype number after biofield
treatment, new organism was identified as Klebsiella oxytoca. It is
assumed that biofield treatment could be applied in biomedical health
care system in future to improve the antimicrobial potency that
enhance human well-being.
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